BRPI1013333A2 - método para produzir olmesartan medoxomil - Google Patents
método para produzir olmesartan medoxomilInfo
- Publication number
- BRPI1013333A2 BRPI1013333A2 BRPI1013333A BRPI1013333A BRPI1013333A2 BR PI1013333 A2 BRPI1013333 A2 BR PI1013333A2 BR PI1013333 A BRPI1013333 A BR PI1013333A BR PI1013333 A BRPI1013333 A BR PI1013333A BR PI1013333 A2 BRPI1013333 A2 BR PI1013333A2
- Authority
- BR
- Brazil
- Prior art keywords
- produce
- olmesartan medoxomil
- medoxomil
- olmesartan
- produce olmesartan
- Prior art date
Links
- 239000002051 C09CA08 - Olmesartan medoxomil Substances 0.000 title 1
- UQGKUQLKSCSZGY-UHFFFAOYSA-N Olmesartan medoxomil Chemical compound C=1C=C(C=2C(=CC=CC=2)C2=NNN=N2)C=CC=1CN1C(CCC)=NC(C(C)(C)O)=C1C(=O)OCC=1OC(=O)OC=1C UQGKUQLKSCSZGY-UHFFFAOYSA-N 0.000 title 1
- 229960001199 olmesartan medoxomil Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009-109159 | 2009-04-28 | ||
| JP2009109159 | 2009-04-28 | ||
| PCT/JP2010/057403 WO2010126013A1 (ja) | 2009-04-28 | 2010-04-27 | オルメサルタンメドキソミルの製造方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI1013333A2 true BRPI1013333A2 (pt) | 2016-03-29 |
| BRPI1013333B1 BRPI1013333B1 (pt) | 2020-10-20 |
| BRPI1013333B8 BRPI1013333B8 (pt) | 2021-05-25 |
Family
ID=43032158
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1013333A BRPI1013333B8 (pt) | 2009-04-28 | 2010-04-27 | método para produzir olmesartana medoxomila |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8933241B2 (pt) |
| EP (1) | EP2426126B1 (pt) |
| JP (1) | JP5595383B2 (pt) |
| KR (1) | KR101676512B1 (pt) |
| CN (1) | CN102414200B (pt) |
| BR (1) | BRPI1013333B8 (pt) |
| CA (1) | CA2759163C (pt) |
| ES (1) | ES2527686T3 (pt) |
| IL (1) | IL215966A (pt) |
| TW (1) | TWI539948B (pt) |
| WO (1) | WO2010126013A1 (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2753874T3 (es) * | 2009-04-28 | 2020-04-14 | Daiichi Sankyo Co Ltd | Cristales de solvato novedosos |
| JP2014152127A (ja) * | 2013-02-06 | 2014-08-25 | Tokuyama Corp | オルメサルタンメドキソミルの製造方法 |
| CN103719825A (zh) * | 2013-12-19 | 2014-04-16 | 芜湖佳诚电子科技有限公司 | 一种保健香菇粉及其制备方法 |
| CN110082449B (zh) * | 2019-05-24 | 2020-05-19 | 珠海润都制药股份有限公司 | 一种奥美沙坦酯中三苯基氯甲烷的检测方法 |
| CN117024418A (zh) * | 2023-07-27 | 2023-11-10 | 迪嘉药业集团股份有限公司 | 一种奥美沙坦酯母液回收方法 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0282519A (ja) | 1988-09-19 | 1990-03-23 | Sanyo Electric Co Ltd | 固相エピタキシャル成長方法 |
| US5616599A (en) | 1991-02-21 | 1997-04-01 | Sankyo Company, Limited | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
| IE920540A1 (en) | 1991-02-21 | 1992-08-26 | Sankyo Co | 1-biphenylmethylimidazole derivatives, their preparation and¹their therapetuic use |
| JPH07121918A (ja) | 1993-08-30 | 1995-05-12 | Tdk Corp | 光磁気記録媒体 |
| JP3671266B2 (ja) | 1996-03-21 | 2005-07-13 | 東洋化成工業株式会社 | ５−置換テトラゾール類の製造方法 |
| JP3521304B2 (ja) | 1996-03-21 | 2004-04-19 | 東洋化成工業株式会社 | １−（テトラゾリルビフェニルメチル）イミダゾール誘導体の製造方法 |
| JP2004217542A (ja) | 2003-01-10 | 2004-08-05 | Fuji Photo Film Co Ltd | ４，５−ジアルコキシカルボニルイミダゾールの製造方法 |
| WO2004065383A2 (en) | 2003-01-16 | 2004-08-05 | Teva Pharmaceutical Industries Ltd. | Novel synthesis of irbesartan |
| US20070054948A1 (en) | 2004-09-02 | 2007-03-08 | Lilach Hedvati | Purification of olmesartan medoxomil |
| US7528258B2 (en) * | 2004-09-02 | 2009-05-05 | Teva Pharmaceutical Industries Ltd | Preparation of olmesartan medoxomil |
| KR100953878B1 (ko) * | 2004-09-02 | 2010-04-22 | 테바 파마슈티컬 인더스트리즈 리미티드 | 올메살탄 메독소밀의 정제 |
| JP2006111586A (ja) | 2004-10-15 | 2006-04-27 | Nippon Petrochemicals Co Ltd | 置換芳香族化合物の酸化方法 |
| KR20090108739A (ko) * | 2005-01-03 | 2009-10-16 | 테바 파마슈티컬 인더스트리즈 리미티드 | 불순물의 양이 감소된 올메사탄 메독소밀 |
| CA2616466A1 (en) | 2005-07-29 | 2007-02-15 | Krka | Process for the preparation of olmesartan medoxomil |
| SI22092A (sl) | 2005-07-29 | 2007-02-28 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Postopek za pripravo olmesartan medoksomila |
| WO2007047838A2 (en) | 2005-10-20 | 2007-04-26 | Dr. Reddy's Laboratories Ltd. | Process for preparing olmesartan medoxomil |
| CZ299902B6 (cs) | 2005-10-27 | 2008-12-29 | Zentiva, A. S | Zpusob odstranování trifenylmethanové chránicí skupiny u prekurzoru antihypertenzních léciv |
| US8048904B2 (en) * | 2006-06-19 | 2011-11-01 | Matrix Laboratories Ltd. | Process for the preparation of olmesartan medoxomil |
| ITMI20061848A1 (it) * | 2006-09-27 | 2008-03-28 | Dipharma Spa | Procedimento per la preparazione di composti feniltetrazolici |
| WO2008043996A2 (en) * | 2006-10-09 | 2008-04-17 | Cipla Limited | Process for preparing trityl olmesartan medoxomil and olmesartan medoxomil |
| EP2036904A1 (en) | 2007-08-08 | 2009-03-18 | LEK Pharmaceuticals D.D. | A process for the preparation of olmesartan medoxomil |
| CA2707365A1 (en) | 2007-08-08 | 2009-02-12 | Lek Pharmaceuticals D.D. | A process for the preparation of olmesartan medoxomil |
| ES2540062T3 (es) | 2008-06-09 | 2015-07-08 | Daiichi Sankyo Company, Limited | Procedimiento de producción de un compuesto de 1-bifenilmetilimidazol |
| WO2010026255A1 (en) | 2008-09-05 | 2010-03-11 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Process for preparing olmesartan medoxomil intermediate |
| WO2011014611A2 (en) | 2009-07-30 | 2011-02-03 | Dr. Reddy's Laboratories Ltd. | Preparation of olmesartan medoxomil |
| WO2012001694A1 (en) | 2010-06-28 | 2012-01-05 | Hetero Research Foundation | Process for olmesartan medoxomil |
-
2010
- 2010-04-27 TW TW099113170A patent/TWI539948B/zh active
- 2010-04-27 CA CA2759163A patent/CA2759163C/en active Active
- 2010-04-27 US US13/266,885 patent/US8933241B2/en active Active
- 2010-04-27 CN CN201080018897.0A patent/CN102414200B/zh active Active
- 2010-04-27 JP JP2011511395A patent/JP5595383B2/ja active Active
- 2010-04-27 KR KR1020117025159A patent/KR101676512B1/ko active Active
- 2010-04-27 ES ES10769711.2T patent/ES2527686T3/es active Active
- 2010-04-27 BR BRPI1013333A patent/BRPI1013333B8/pt active IP Right Grant
- 2010-04-27 WO PCT/JP2010/057403 patent/WO2010126013A1/ja not_active Ceased
- 2010-04-27 EP EP10769711.2A patent/EP2426126B1/en active Active
-
2011
- 2011-10-26 IL IL215966A patent/IL215966A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| KR101676512B1 (ko) | 2016-11-15 |
| IL215966A (en) | 2014-01-30 |
| HK1166504A1 (en) | 2012-11-02 |
| CA2759163A1 (en) | 2010-11-04 |
| IL215966A0 (en) | 2012-01-31 |
| WO2010126013A1 (ja) | 2010-11-04 |
| KR20120006512A (ko) | 2012-01-18 |
| US8933241B2 (en) | 2015-01-13 |
| BRPI1013333B8 (pt) | 2021-05-25 |
| EP2426126A1 (en) | 2012-03-07 |
| CA2759163C (en) | 2015-02-17 |
| ES2527686T3 (es) | 2015-01-28 |
| EP2426126B1 (en) | 2014-11-19 |
| CN102414200B (zh) | 2014-12-17 |
| CN102414200A (zh) | 2012-04-11 |
| JP5595383B2 (ja) | 2014-09-24 |
| TWI539948B (zh) | 2016-07-01 |
| TW201043617A (en) | 2010-12-16 |
| JPWO2010126013A1 (ja) | 2012-11-01 |
| EP2426126A4 (en) | 2012-10-17 |
| BRPI1013333B1 (pt) | 2020-10-20 |
| US20120071665A1 (en) | 2012-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012004707A2 (pt) | método | |
| BR112012000624A2 (pt) | método | |
| FI20090389A0 (fi) | Menetelmä | |
| DK3138854T3 (da) | Antistoffer mod CD40 | |
| FI20095140L (fi) | Menetelmä muokatun selluloosan valmistamiseksi | |
| BRPI1008774A2 (pt) | espiroamida substituída | |
| BRPI1012526A2 (pt) | método | |
| EP2496176A4 (en) | ENTZELLULARISIERUNGSVERFAHREN | |
| BRPI1010705A2 (pt) | método | |
| DK2406243T3 (da) | Benzofuranderivat | |
| EP2414506A4 (en) | IMPROVED ENDOGLUCANASES | |
| BRPI1008253A2 (pt) | Metoso para tratar biomassa | |
| FI20096072A0 (fi) | Hydraulinen sylinteri | |
| BRPI1012532A2 (pt) | método | |
| EP2324768A4 (en) | TOMOGRAPHIC PROCEDURE | |
| BRPI1009350A2 (pt) | método | |
| BR112012022525A2 (pt) | método para produzir butanol | |
| KR101018566B9 (ko) | 내구성 있는 인공암 제작방법 | |
| IT1396969B1 (it) | Metodo di incollaggio | |
| EP2448583A4 (en) | Substituted 4-hydroxypyrimidine-5-carboxamides | |
| ITPD20090053U1 (it) | Paradordi per banchine | |
| BRPI1013333A2 (pt) | método para produzir olmesartan medoxomil | |
| EP2378136A4 (en) | FLUID PRESSURE CYLINDER | |
| BRPI1007418A2 (pt) | método para produzir amônia | |
| DE112010004312A5 (de) | Hydraulikzylinder |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 20/10/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 27/04/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |